Anterior Cruciate Ligament Reconstruction, Pain Management
Conditions
Keywords
Anterior Cruciate Ligament Reconstruction, Adductor Canal Block, Biceps Femoris Short Head Block
Brief summary
Anterior cruciate ligament (ACL) reconstruction is commonly associated with moderate to severe postoperative pain, particularly during the early postoperative period and rehabilitation. Effective postoperative analgesia is important to facilitate early mobilization, improve patient comfort, and reduce opioid consumption and opioid-related adverse effects. Adductor canal block (ACB) is commonly used as part of multimodal analgesia for knee surgery because it provides analgesia while largely preserving quadriceps motor function. However, ACB primarily targets the anteromedial aspect of the knee and may provide limited analgesia for pain arising from the posterior and posterolateral knee. The biceps femoris short head (BiFeS) block is a motor-sparing fascial plane block targeting sensory contributions to the posterolateral knee region. Combining BiFeS block with ACB may therefore provide more comprehensive analgesia than ACB alone. This randomized study aims to compare the postoperative analgesic efficacy of adductor canal block alone with adductor canal block combined with BiFeS block in patients undergoing anterior cruciate ligament reconstruction surgery.
Interventions
PROCEDUREAdductor Canal Block
Ultrasound-guided adductor canal block will be performed using 10 mL of 0.25% bupivacaine.
PROCEDUREBiFeS Block
Ultrasound-guided BiFeS block will be performed using 20 mL of 0.25% bupivacaine.
Sponsors
Ankara Etlik City Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Patients aged 18-65 years * Patients scheduled for elective unilateral anterior cruciate ligament reconstruction surgery * American Society of Anesthesiologists physical status I-III * Patients who provide written informed consent
Exclusion criteria
* Age \<18 or \>65 years * ASA physical status IV or higher * Coagulopathy or ongoing anticoagulant therapy incompatible with peripheral nerve block * Infection at the block injection site * Patient refusal
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pain Score | On the operation day | Pain will be assessed at rest using the visual analog scale on a scale from 0 (no pain) to 100 (worst pain). Pain assessment will be done at 6th hour after surgery. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Pain Scores | On the operation day | Pain will be assessed at rest using the visual analog scale on a scale from 0 (no pain) to 100 (worst pain). Pain assessment will be done at 0st, 1st, 2nd, 12th, and 24th hours after surgery. |
| Total Postoperative Morphine Consumption During the First 24 Hours AfterSurgery | On the operation day | Total Postoperative Morphine Consumption During the First 24 HoursAfter Surgery |
Countries
Turkey (Türkiye)
Contacts
CONTACTAtakan Sezgi
CONTACTJülide Ergil
Outcome results
None listed